Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Pharma (IGC) over the last 14 years, with Q3 2025 value amounting to $105000.0.

  • Pharma's Depreciation and Depletion fell 2758.62% to $105000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $512000.0, marking a year-over-year decrease of 1064.57%. This contributed to the annual value of $567000.0 for FY2025, which is 71.05% up from last year.
  • Latest data reveals that Pharma reported Depreciation and Depletion of $105000.0 as of Q3 2025, which was down 2758.62% from $127000.0 recorded in Q2 2025.
  • Pharma's 5-year Depreciation and Depletion high stood at $200000.0 for Q1 2022, and its period low was -$49000.0 during Q1 2023.
  • For the 5-year period, Pharma's Depreciation and Depletion averaged around $135000.0, with its median value being $144000.0 (2024).
  • Per our database at Business Quant, Pharma's Depreciation and Depletion crashed by 12450.0% in 2023 and then skyrocketed by 39795.92% in 2024.
  • Quarter analysis of 5 years shows Pharma's Depreciation and Depletion stood at $117000.0 in 2021, then skyrocketed by 35.04% to $158000.0 in 2022, then fell by 11.39% to $140000.0 in 2023, then rose by 2.86% to $144000.0 in 2024, then decreased by 27.08% to $105000.0 in 2025.
  • Its Depreciation and Depletion was $105000.0 in Q3 2025, compared to $127000.0 in Q2 2025 and $136000.0 in Q1 2025.